{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:04:19Z","timestamp":1787763859583,"version":"build-2784847793"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ERANET TRANSCAN","award":["PurTher"],"award-info":[{"award-number":["PurTher"]}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022 5LKPYA"],"award-info":[{"award-number":["PRIN 2022 5LKPYA"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"crossref","award":["PRESTO COST Action CA21130"],"award-info":[{"award-number":["PRESTO COST Action CA21130"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Extracellular adenosine triphosphate (eATP) is a hallmark of inflammatory and tumor-associated microenvironments, where it functions as a key extracellular signalling molecule through activation of purinergic receptors. In the gastrointestinal tract, and particularly in the colon, eATP-mediated signalling regulates epithelial barrier function, neuroimmune interactions, and immune responses. P2X receptors, a family of eATP-gated ion channels, are differentially expressed across epithelial, neuronal, and immune cell populations and are increasingly recognized as contributors to colonic pathophysiology. This review summarizes current evidence on the roles of P2X receptors in inflammatory bowel disease and colon carcinoma, highlighting their involvement in intestinal inflammation, visceral hypersensitivity, immune cell activation, and tumor-associated processes. We discuss how dysregulated P2X receptor signalling contributes to chronic inflammation and supports a tumor-promoting microenvironment, while also emphasizing the context- and cell-type-specific nature of these responses. Finally, we outline emerging therapeutic strategies targeting P2X receptors and underscore the importance of personalized approaches based on receptor expression patterns within the colonic tissue.<\/jats:p>","DOI":"10.1007\/s11302-026-10146-6","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:38:18Z","timestamp":1773815898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Latest advances on the role of P2X Receptors in colorectal inflammation and cancer"],"prefix":"10.1007","volume":"22","author":[{"given":"Luigia","family":"Ruo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Grignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Adinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"7","key":"10146_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002599","volume":"3","author":"P Pellegatti","year":"2008","unstructured":"Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3(7):e2599. https:\/\/doi.org\/10.1371\/journal.pone.0002599","journal-title":"PLoS One"},{"issue":"12","key":"10146_CR2","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1016\/j.celrep.2017.11.079","volume":"21","author":"J Amores-Iniesta","year":"2017","unstructured":"Amores-Iniesta J, Barbera-Cremades M, Martinez CM, Pons JA, Revilla-Nuin B, Martinez-Alarcon L et al (2017) Extracellular ATP activates the NLRP3 inflammasome and is an early danger signal of skin allograft rejection. Cell Rep 21(12):3414\u20133426. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.079","journal-title":"Cell Rep"},{"issue":"12","key":"10146_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/nm.2242","volume":"16","author":"K Wilhelm","year":"2010","unstructured":"Wilhelm K, Ganesan J, Muller T, Durr C, Grimm M, Beilhack A et al (2010) Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat Med 16(12):1434\u20131438. https:\/\/doi.org\/10.1038\/nm.2242","journal-title":"Nat Med"},{"issue":"18","key":"10146_CR4","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-19-3807","volume":"80","author":"A Romagnani","year":"2020","unstructured":"Romagnani A, Rottoli E, Mazza EMC, Rezzonico-Jost T, De Ponte Conti B, Proietti M et al (2020) P2X7 receptor activity limits accumulation of T cells within tumors. Cancer Res 80(18):3906\u20133919. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3807","journal-title":"Cancer Res"},{"issue":"1","key":"10146_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02601-z","volume":"19","author":"M Wilmes","year":"2022","unstructured":"Wilmes M, Pinto Espinoza C, Ludewig P, Stabernack J, Liesz A, Nicke A et al (2022) Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions. J Neuroinflammation 19(1):256. https:\/\/doi.org\/10.1186\/s12974-022-02601-z","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10146_CR6","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1096\/fj.12-205765","volume":"26","author":"M Barbera-Cremades","year":"2012","unstructured":"Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrin P (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J 26(7):2951\u20132962. https:\/\/doi.org\/10.1096\/fj.12-205765","journal-title":"FASEB J"},{"key":"10146_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.mcb.2025.02.014","volume":"199","author":"M Tarantini","year":"2025","unstructured":"Tarantini M, Vultaggio-Poma V, Falzoni S, Adinolfi E, Giuliani AL, Di Virgilio F (2025) In-vivo measurement of the extracellular ATP concentration by bio-luminescence: the pmeLUC probe. Methods Cell Biol 199:53\u201366. https:\/\/doi.org\/10.1016\/bs.mcb.2025.02.014","journal-title":"Methods Cell Biol"},{"issue":"3","key":"10146_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206","journal-title":"Oncogene"},{"issue":"15","key":"10146_CR9","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1074\/jbc.M805805200","volume":"284","author":"E Adinolfi","year":"2009","unstructured":"Adinolfi E, Callegari MG, Cirillo M, Pinton P, Giorgi C, Cavagna D et al (2009) Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis. J Biol Chem 284(15):10120\u201310128. https:\/\/doi.org\/10.1074\/jbc.M805805200","journal-title":"J Biol Chem"},{"key":"10146_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2019.02.012","volume":"47","author":"E Adinolfi","year":"2019","unstructured":"Adinolfi E, De Marchi E, Orioli E, Pegoraro A, Di Virgilio F (2019) Role of the P2X7 receptor in tumor-associated inflammation. Curr Opin Pharmacol 47:59\u201364. https:\/\/doi.org\/10.1016\/j.coph.2019.02.012","journal-title":"Curr Opin Pharmacol"},{"key":"10146_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.coph.2017.10.011","volume":"37","author":"G Burnstock","year":"2017","unstructured":"Burnstock G, Jacobson KA, Christofi FL (2017) Purinergic drug targets for gastrointestinal disorders. Curr Opin Pharmacol 37:131\u2013141. https:\/\/doi.org\/10.1016\/j.coph.2017.10.011","journal-title":"Curr Opin Pharmacol"},{"key":"10146_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813906","author":"E Adinolfi","year":"2023","unstructured":"Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A (2023) The P2X7 receptor in oncogenesis and metastatic dissemination: new insights on vesicular release and adenosinergic crosstalk. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241813906","journal-title":"Int J Mol Sci"},{"key":"10146_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1006384","volume":"10","author":"M Zanoni","year":"2022","unstructured":"Zanoni M, Pegoraro A, Adinolfi E, De Marchi E (2022) Emerging roles of purinergic signaling in anti-cancer therapy resistance. Front Cell Dev Biol 10:1006384. https:\/\/doi.org\/10.3389\/fcell.2022.1006384","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10146_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47(1):15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"10146_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2019.03.010","volume":"151","author":"I von Kugelgen","year":"2019","unstructured":"von Kugelgen I (2019) Pharmacology of P2Y receptors. Brain Res Bull 151:12\u201324. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.03.010","journal-title":"Brain Res Bull"},{"key":"10146_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells14130984","author":"D Dal Ben","year":"2025","unstructured":"Dal Ben D, Buccioni M, Lambertucci C, Francucci B, Smirnov A, Spinaci A et al (2025) Radioligands targeting the purinergic P2X receptors. Cells. https:\/\/doi.org\/10.3390\/cells14130984","journal-title":"Cells"},{"issue":"2","key":"10146_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11302-022-09850-w","volume":"18","author":"C Sattler","year":"2022","unstructured":"Sattler C, Benndorf K (2022) Enlightening activation gating in P2X receptors. Purinergic Signal 18(2):177\u2013191. https:\/\/doi.org\/10.1007\/s11302-022-09850-w","journal-title":"Purinergic Signal"},{"key":"10146_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15299","author":"P Illes","year":"2020","unstructured":"Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ et al (2020) Update of P2X receptor properties and their pharmacology: IUPHAR review 30. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.15299","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10146_CR19","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1111\/bph.70231","volume":"182","author":"SPH Alexander","year":"2025","unstructured":"Alexander SPH, Striessnig J, Gibb AJ, Mathie AA, Veale EL, Kelly E et al (2025) The Concise Guide to PHARMACOLOGY 2025\/26: Ion channels. Br J Pharmacol 182(Suppl 1):S152\u2013S241. https:\/\/doi.org\/10.1111\/bph.70231","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10146_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013\u20131067. https:\/\/doi.org\/10.1152\/physrev.00015.2002","journal-title":"Physiol Rev"},{"issue":"5","key":"10146_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tcb.2018.01.005","volume":"28","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Schmalzing G, Markwardt F (2018) The elusive P2X7 macropore. Trends Cell Biol 28(5):392\u2013404. https:\/\/doi.org\/10.1016\/j.tcb.2018.01.005","journal-title":"Trends Cell Biol"},{"issue":"6","key":"10146_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1124\/mol.110.063636","volume":"77","author":"S Kotnis","year":"2010","unstructured":"Kotnis S, Bingham B, Vasilyev DV, Miller SW, Bai Y, Yeola S et al (2010) Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform. Mol Pharmacol 77(6):953\u2013960. https:\/\/doi.org\/10.1124\/mol.110.063636","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10146_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11302-022-09903-0","volume":"19","author":"BF King","year":"2023","unstructured":"King BF (2023) Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function. Purinergic Signal 19(2):421\u2013439. https:\/\/doi.org\/10.1007\/s11302-022-09903-0","journal-title":"Purinergic Signal"},{"issue":"5","key":"10146_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1124\/mol.105.020404","volume":"69","author":"SJ Ormond","year":"2006","unstructured":"Ormond SJ, Barrera NP, Qureshi OS, Henderson RM, Edwardson JM, Murrell-Lagnado RD (2006) An uncharged region within the N terminus of the P2X6 receptor inhibits its assembly and exit from the endoplasmic reticulum. Mol Pharmacol 69(5):1692\u20131700. https:\/\/doi.org\/10.1124\/mol.105.020404","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10146_CR25","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.febslet.2014.04.048","volume":"588","author":"LS Antonio","year":"2014","unstructured":"Antonio LS, Stewart AP, Varanda WA, Edwardson JM (2014) Identification of P2X2\/P2X4\/P2X6 heterotrimeric receptors using atomic force microscopy (AFM) imaging. FEBS Lett 588(12):2125\u20132128. https:\/\/doi.org\/10.1016\/j.febslet.2014.04.048","journal-title":"FEBS Lett"},{"key":"10146_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00311","volume":"10","author":"EF Diezmos","year":"2016","unstructured":"Diezmos EF, Bertrand PP, Liu L (2016) Purinergic signaling in gut inflammation: the role of connexins and pannexins. Front Neurosci 10:311. https:\/\/doi.org\/10.3389\/fnins.2016.00311","journal-title":"Front Neurosci"},{"issue":"7152","key":"10146_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427\u2013434. https:\/\/doi.org\/10.1038\/nature06005","journal-title":"Nature"},{"issue":"40","key":"10146_CR28","doi-asserted-by":"publisher","first-page":"14805","DOI":"10.3748\/wjg.v20.i40.14805","volume":"20","author":"ZK Wang","year":"2014","unstructured":"Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH (2014) Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 20(40):14805\u201314820. https:\/\/doi.org\/10.3748\/wjg.v20.i40.14805","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10146_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/ecco-jcc\/jjad203","volume":"18","author":"C Kapizioni","year":"2024","unstructured":"Kapizioni C, Desoki R, Lam D, Balendran K, Al-Sulais E, Subramanian S et al (2024) Biologic therapy for inflammatory bowel disease: real-world comparative effectiveness and impact of drug sequencing in 13 222 patients within the UK IBD BioResource. J Crohns Colitis 18(6):790\u2013800. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad203","journal-title":"J Crohns Colitis"},{"key":"10146_CR30","doi-asserted-by":"publisher","unstructured":"Katsandegwaza B, Horsnell W, Smith K (2022) Inflammatory bowel disease: A review of pre-clinical murine models of human disease. Int J Mol Sci 23(16).\u00a0https:\/\/doi.org\/10.3390\/ijms23169344","DOI":"10.3390\/ijms23169344"},{"issue":"1\u20132","key":"10146_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ans.17297","volume":"92","author":"CI Wells","year":"2022","unstructured":"Wells CI, Milne TGE, Seo SHB, Chapman SJ, Vather R, Bissett IP et al (2022) Post-operative ileus: definitions, mechanisms and controversies. ANZ J Surg 92(1\u20132):62\u201368. https:\/\/doi.org\/10.1111\/ans.17297","journal-title":"ANZ J Surg"},{"key":"10146_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696766","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Yuan X, Su Y, Hu J, Ji Q, Fu S et al (2021) Targeting purinergic receptor P2RX1 modulates intestinal microbiota and alleviates inflammation in colitis. Front Immunol 12:696766. https:\/\/doi.org\/10.3389\/fimmu.2021.696766","journal-title":"Front Immunol"},{"issue":"1","key":"10146_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/jth.14620","volume":"18","author":"O Wera","year":"2020","unstructured":"Wera O, Lecut C, Servais L, Hego A, Delierneux C, Jiang Z et al (2020) P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis. J Thromb Haemost 18(1):44\u201356. https:\/\/doi.org\/10.1111\/jth.14620","journal-title":"J Thromb Haemost"},{"key":"10146_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104901","volume":"408","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang F, Liu Z, Li M, Wu G, Li H (2025) P2RX1-blocked neutrophils induce CD8(+) T cell dysfunction and affect the immune escape of gastric cancer cells. Cell Immunol 408:104901. https:\/\/doi.org\/10.1016\/j.cellimm.2024.104901","journal-title":"Cell Immunol"},{"issue":"1","key":"10146_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00438-025-02227-9","volume":"300","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang F, Liu Z, Li M, Wu G, Li H (2025) P2RX1 in neutrophils mediates JAK\/STAT signaling pathway to regulate malignant phenotype of gastric Cancer cells. Mol Genet Genomics 300(1):23. https:\/\/doi.org\/10.1007\/s00438-025-02227-9","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"10146_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012724","volume":"13","author":"R Schneider","year":"2021","unstructured":"Schneider R, Leven P, Glowka T, Kuzmanov I, Lysson M, Schneiker B et al (2021) A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation. EMBO Mol Med 13(1):e12724. https:\/\/doi.org\/10.15252\/emmm.202012724","journal-title":"EMBO Mol Med"},{"issue":"23","key":"10146_CR37","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.231474098","volume":"98","author":"A Cornet","year":"2001","unstructured":"Cornet A, Savidge TC, Cabarrocas J, Deng WL, Colombel JF, Lassmann H et al (2001) Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn\u2019s disease? Proc Natl Acad Sci U S A 98(23):13306\u201313311. https:\/\/doi.org\/10.1073\/pnas.231474098","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10146_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114309","volume":"187","author":"K Inoue","year":"2021","unstructured":"Inoue K, Tsuda M (2021) Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors. Biochem Pharmacol 187:114309. https:\/\/doi.org\/10.1016\/j.bcp.2020.114309","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10146_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123810","volume":"10","author":"A Deiteren","year":"2015","unstructured":"Deiteren A, van der Linden L, de Wit A, Ceuleers H, Buckinx R, Timmermans JP et al (2015) P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization. PLoS ONE 10(4):e0123810. https:\/\/doi.org\/10.1371\/journal.pone.0123810","journal-title":"PLoS ONE"},{"key":"10146_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872760","volume":"13","author":"EE Valdez-Morales","year":"2022","unstructured":"Valdez-Morales EE, Sanchez-Navarro CA, Reyes-Pavon D, Barrios-Garcia T, Ochoa-Cortes F, Barajas-Espinosa A et al (2022) TNF-\u03b1 enhances sensory DRG neuron excitability through modulation of P2X3 receptors in an acute colitis model. Front Immunol 13:872760. https:\/\/doi.org\/10.3389\/fimmu.2022.872760","journal-title":"Front Immunol"},{"issue":"8","key":"10146_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/1061186X.2024.2367563","volume":"32","author":"C Di Salvo","year":"2024","unstructured":"Di Salvo C, D\u2019Antongiovanni V, Benvenuti L, Fornai M, Valdiserra G, Natale G et al (2024) The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis. J Drug Target 32(8):953\u2013963. https:\/\/doi.org\/10.1080\/1061186X.2024.2367563","journal-title":"J Drug Target"},{"issue":"21","key":"10146_CR42","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1111\/bph.15928","volume":"179","author":"J Ballout","year":"2022","unstructured":"Ballout J, Classen R, Richter K, Grau V, Diener M (2022) Ionotropic P2X4 and P2X7 receptors in the regulation of ion transport across rat colon. Br J Pharmacol 179(21):4992\u20135011. https:\/\/doi.org\/10.1111\/bph.15928","journal-title":"Br J Pharmacol"},{"key":"10146_CR43","doi-asserted-by":"publisher","unstructured":"Tani H, Li B, Kusu T, Okumura R, Nishimura J, Okuzaki D et al (2021) The ATP-hydrolyzing ectoenzyme E-NTPD8 attenuates colitis through modulation of P2X4 receptor-dependent metabolism in myeloid cells. Proc Natl Acad Sci U S A 118(39).\u00a0https:\/\/doi.org\/10.1073\/pnas.2100594118","DOI":"10.1073\/pnas.2100594118"},{"issue":"12","key":"10146_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116253","volume":"9","author":"L Antonioli","year":"2014","unstructured":"Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V et al (2014) Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats. PLoS One 9(12):e116253. https:\/\/doi.org\/10.1371\/journal.pone.0116253","journal-title":"PLoS One"},{"key":"10146_CR45","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/ncomms2023","volume":"3","author":"Y Kurashima","year":"2012","unstructured":"Kurashima Y, Amiya T, Nochi T, Fujisawa K, Haraguchi T, Iba H et al (2012) Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 3:1034. https:\/\/doi.org\/10.1038\/ncomms2023","journal-title":"Nat Commun"},{"issue":"4","key":"10146_CR46","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm.2679","volume":"18","author":"BD Gulbransen","year":"2012","unstructured":"Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA et al (2012) Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med 18(4):600\u2013604. https:\/\/doi.org\/10.1038\/nm.2679","journal-title":"Nat Med"},{"issue":"1","key":"10146_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbadis.2013.10.012","volume":"1842","author":"CC Marques","year":"2014","unstructured":"Marques CC, Castelo-Branco MT, Pacheco RG, Buongusto F, do Rosario A Jr., Schanaider A et al (2014) Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim Biophys Acta 1842(1):65\u201378. https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.012","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10146_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/01.MIB.0000441201.10454.06","volume":"20","author":"AR Neves","year":"2014","unstructured":"Neves AR, Castelo-Branco MT, Figliuolo VR, Bernardazzi C, Buongusto F, Yoshimoto A et al (2014) Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn\u2019s disease. Inflamm Bowel Dis 20(3):444\u2013457. https:\/\/doi.org\/10.1097\/01.MIB.0000441201.10454.06","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10146_CR49","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1097\/MIB.0000000000000514","volume":"21","author":"A Eser","year":"2015","unstructured":"Eser A, Colombel JF, Rutgeerts P, Vermeire S, Vogelsang H, Braddock M et al (2015) Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn\u2019s disease: a randomized placebo-controlled, double-blind, phase IIa study. Inflamm Bowel Dis 21(10):2247\u20132253. https:\/\/doi.org\/10.1097\/MIB.0000000000000514","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10146_CR50","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1021\/acs.jmedchem.9b00584","volume":"63","author":"G Homerin","year":"2020","unstructured":"Homerin G, Jawhara S, Dezitter X, Baudelet D, Dufrenoy P, Rigo B et al (2020) Pyroglutamide-based P2X7 receptor antagonists targeting inflammatory bowel disease. J Med Chem 63(5):2074\u20132094. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00584","journal-title":"J Med Chem"},{"issue":"1","key":"10146_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12951-023-02285-4","volume":"22","author":"C Abad","year":"2024","unstructured":"Abad C, Demeules M, Guillou C, Gonde H, Zoubairi R, Tan YV et al (2024) Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice. J Nanobiotechnology 22(1):27. https:\/\/doi.org\/10.1186\/s12951-023-02285-4","journal-title":"J Nanobiotechnology"},{"key":"10146_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1012534","volume":"13","author":"M Demeules","year":"2022","unstructured":"Demeules M, Scarpitta A, Hardet R, Gonde H, Abad C, Blandin M et al (2022) Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo. Front Immunol 13:1012534. https:\/\/doi.org\/10.3389\/fimmu.2022.1012534","journal-title":"Front Immunol"},{"issue":"6","key":"10146_CR53","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.bbadis.2017.03.004","volume":"1863","author":"VR Figliuolo","year":"2017","unstructured":"Figliuolo VR, Savio LEB, Safya H, Nanini H, Bernardazzi C, Abalo A et al (2017) P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells. Biochim Biophys Acta Mol Basis Dis 1863(6):1183\u20131194. https:\/\/doi.org\/10.1016\/j.bbadis.2017.03.004","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"10146_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00418-023-02208-2","volume":"160","author":"FA Machado","year":"2023","unstructured":"Machado FA, Souza RF, Figliuolo VR, Coutinho-Silva R, Castelucci P (2023) Effects of experimental ulcerative colitis on myenteric neurons in P2X7-knockout mice. Histochem Cell Biol 160(4):321\u2013339. https:\/\/doi.org\/10.1007\/s00418-023-02208-2","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10146_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mucimm.2022.11.003","volume":"16","author":"T Jooss","year":"2023","unstructured":"Jooss T, Zhang J, Zimmer B, Rezzonico-Jost T, Rissiek B, Felipe Pelczar P et al (2023) Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system-no evidence for the role of neuronal P2X7 receptors in colitis. Mucosal Immunol 16(2):180\u2013193. https:\/\/doi.org\/10.1016\/j.mucimm.2022.11.003","journal-title":"Mucosal Immunol"},{"key":"10146_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123971","volume":"380","author":"L Oliveira-Cruz","year":"2025","unstructured":"Oliveira-Cruz L, Carvalho-Barbosa N, Cristina-Rodrigues F, Cortes TN, Guimaraes-Pinto K, Amorim da Costa AL et al (2025) Role of the P2X7 receptor in intestinal inflammation due to infection with the oral pathogen Porphyromonas gingivalis. Life Sci 380:123971. https:\/\/doi.org\/10.1016\/j.lfs.2025.123971","journal-title":"Life Sci"},{"issue":"1","key":"10146_CR57","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-024-45473-y","volume":"15","author":"L Jia","year":"2024","unstructured":"Jia L, Jiang Y, Wu L, Fu J, Du J, Luo Z et al (2024) Porphyromonas gingivalis aggravates colitis via a gut microbiota-linoleic acid metabolism-Th17\/Treg cell balance axis. Nat Commun 15(1):1617. https:\/\/doi.org\/10.1038\/s41467-024-45473-y","journal-title":"Nat Commun"},{"issue":"9","key":"10146_CR58","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.7150\/jca.83395","volume":"14","author":"M Kerdreux","year":"2023","unstructured":"Kerdreux M, Edin S, Lowenmark T, Bronnec V, Lofgren-Burstrom A, Zingmark C et al (2023) Porphyromonas gingivalis in colorectal cancer and its association to patient prognosis. J Cancer 14(9):1479\u20131485. https:\/\/doi.org\/10.7150\/jca.83395","journal-title":"J Cancer"},{"issue":"8","key":"10146_CR59","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1172\/JCI94524","volume":"128","author":"F D'Addio","year":"2018","unstructured":"D\u2019Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M et al (2018) P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest 128(8):3490\u20133503. https:\/\/doi.org\/10.1172\/JCI94524","journal-title":"J Clin Invest"},{"key":"10146_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.876510","volume":"10","author":"E De Marchi","year":"2022","unstructured":"De Marchi E, Pegoraro A, Turiello R, Di Virgilio F, Morello S, Adinolfi E (2022) A2A receptor contributes to tumor progression in P2X7 null mice. Front Cell Dev Biol 10:876510. https:\/\/doi.org\/10.3389\/fcell.2022.876510","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10146_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451196","volume":"55","author":"A Elhage","year":"2025","unstructured":"Elhage A, Watson D, Sluyter R (2025) The anti-human P2X7 monoclonal antibody (clone L4) can mediate complement-dependent cytotoxicity of human leukocytes. Eur J Immunol 55(1):e202451196. https:\/\/doi.org\/10.1002\/eji.202451196","journal-title":"Eur J Immunol"},{"issue":"1","key":"10146_CR62","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-025-07897-2","volume":"16","author":"A Pegoraro","year":"2025","unstructured":"Pegoraro A, De Marchi E, Ruo L, Zanoni M, Chioccioli S, Caderni G et al (2025) P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A\/CD39\/CD73 axis. Cell Death Dis 16(1):587. https:\/\/doi.org\/10.1038\/s41419-025-07897-2","journal-title":"Cell Death Dis"},{"issue":"11","key":"10146_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.70061","volume":"14","author":"A Elhage","year":"2025","unstructured":"Elhage A, Hadaya JH, Sligar C, Watson D, Adriouch S, Sluyter R (2025) Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model. Clin Transl Immunol 14(11):e70061. https:\/\/doi.org\/10.1002\/cti2.70061","journal-title":"Clin Transl Immunol"},{"key":"10146_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612936","author":"L Lis-Lopez","year":"2023","unstructured":"Lis-Lopez L, Bauset C, Seco-Cervera M, Macias-Ceja D, Navarro F, Alvarez A et al (2023) P2X7 receptor regulates collagen expression in human intestinal fibroblasts: relevance in intestinal fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612936","journal-title":"Int J Mol Sci"},{"key":"10146_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0037-0","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"10146_CR66","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0328","author":"M Kamata-Sakurai","year":"2020","unstructured":"Kamata-Sakurai M, Narita Y, Hori Y, Nemoto T, Uchikawa R, Honda M et al (2020) Antibody to CD137 activated by extracellular adenosine triphosphate is tumor selective and broadly effective in vivo without systemic immune activation. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0328","journal-title":"Cancer Discov"},{"issue":"12","key":"10146_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108542","volume":"33","author":"F Mimoto","year":"2020","unstructured":"Mimoto F, Tatsumi K, Shimizu S, Kadono S, Haraya K, Nagayasu M et al (2020) Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep 33(12):108542. https:\/\/doi.org\/10.1016\/j.celrep.2020.108542","journal-title":"Cell Rep"},{"issue":"10","key":"10146_CR68","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41419-020-03058-9","volume":"11","author":"A Pegoraro","year":"2020","unstructured":"Pegoraro A, Orioli E, De Marchi E, Salvestrini V, Milani A, Di Virgilio F et al (2020) Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression. Cell Death Dis 11(10):876. https:\/\/doi.org\/10.1038\/s41419-020-03058-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"10146_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04526-0","volume":"13","author":"M Zanoni","year":"2022","unstructured":"Zanoni M, Sarti AC, Zamagni A, Cortesi M, Pignatta S, Arienti C et al (2022) Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma. Cell Death Dis 13(1):80. https:\/\/doi.org\/10.1038\/s41419-022-04526-0","journal-title":"Cell Death Dis"},{"issue":"10","key":"10146_CR70","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard B, Allard D, Buisseret L, Stagg J (2020) The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 17(10):611\u2013629. https:\/\/doi.org\/10.1038\/s41571-020-0382-2","journal-title":"Nat Rev Clin Oncol"},{"key":"10146_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713503","author":"H Waldum","year":"2023","unstructured":"Waldum H, Fossmark R (2023) Inflammation and digestive cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713503","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10146_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683\u2013691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","journal-title":"Gut"},{"key":"10146_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147857","volume":"892","author":"M Housini","year":"2024","unstructured":"Housini M, Dariya B, Ahmed N, Stevens A, Fiadjoe H, Nagaraju GP et al (2024) Colorectal cancer: genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene 892:147857. https:\/\/doi.org\/10.1016\/j.gene.2023.147857","journal-title":"Gene"},{"issue":"8","key":"10146_CR74","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jso.27320","volume":"127","author":"BJ Kim","year":"2023","unstructured":"Kim BJ, Hanna MH (2023) Colorectal cancer in young adults. J Surg Oncol 127(8):1247\u20131251. https:\/\/doi.org\/10.1002\/jso.27320","journal-title":"J Surg Oncol"},{"key":"10146_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7241942","volume":"2020","author":"QQ Dai","year":"2020","unstructured":"Dai QQ, Wang YY, Jiang YP, Li L, Wang HJ (2020) VSNL1 promotes gastric cancer cell proliferation and migration by regulating P2X3\/P2Y2 receptors and is a clinical indicator of poor prognosis in gastric cancer patients. Gastroenterol Res Pract 2020:7241942. https:\/\/doi.org\/10.1155\/2020\/7241942","journal-title":"Gastroenterol Res Pract"},{"key":"10146_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.humpath.2017.03.019","volume":"64","author":"F Qian","year":"2017","unstructured":"Qian F, Xiao J, Hu B, Sun N, Yin W, Zhu J (2017) High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer. Hum Pathol 64:61\u201368. https:\/\/doi.org\/10.1016\/j.humpath.2017.03.019","journal-title":"Hum Pathol"},{"issue":"2","key":"10146_CR77","first-page":"107","volume":"13","author":"I Calik","year":"2020","unstructured":"Calik I, Calik M, Turken G, Ozercan IH (2020) A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor. Int J Clin Exp Pathol 13(2):107\u2013121","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"10146_CR78","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.advms.2019.05.002","volume":"64","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ding J, Wang L (2019) The role of P2X7 receptor in prognosis and metastasis of colorectal cancer. Adv Med Sci 64(2):388\u2013394. https:\/\/doi.org\/10.1016\/j.advms.2019.05.002","journal-title":"Adv Med Sci"},{"issue":"12","key":"10146_CR79","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","volume":"72","author":"E Adinolfi","year":"2012","unstructured":"Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P et al (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72(12):2957\u20132969. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1947","journal-title":"Cancer Res"},{"key":"10146_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15708","author":"C Yang","year":"2020","unstructured":"Yang C, Shi S, Su Y, Tong JS, Li L (2020) P2X7R promotes angiogenesis and tumour-associated macrophage recruitment by regulating the NF-kappaB signalling pathway in colorectal cancer cells. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.15708","journal-title":"J Cell Mol Med"},{"issue":"41","key":"10146_CR81","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/onc.2014.444","volume":"34","author":"F Amoroso","year":"2015","unstructured":"Amoroso F, Capece M, Rotondo A, Cangelosi D, Ferracin M, Franceschini A et al (2015) The P2X7 receptor is a key modulator of the PI3K\/GSK3beta\/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34(41):5240\u20135251. https:\/\/doi.org\/10.1038\/onc.2014.444","journal-title":"Oncogene"},{"key":"10146_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174041","volume":"899","author":"WJ Zhang","year":"2021","unstructured":"Zhang WJ, Luo C, Huang C, Pu FQ, Zhu JF, Zhu ZM (2021) PI3K\/Akt\/GSK-3beta signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. Eur J Pharmacol 899:174041. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174041","journal-title":"Eur J Pharmacol"},{"key":"10146_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbrc.2021.04.076","volume":"558","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li F, Wang L, Lou Y (2021) A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor. Biochem Biophys Res Commun 558:147\u2013153. https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.076","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10146_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04378-0","volume":"12","author":"A Pegoraro","year":"2021","unstructured":"Pegoraro A, De Marchi E, Ferracin M, Orioli E, Zanoni M, Bassi C et al (2021) P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells. Cell Death Dis 12(12):1088. https:\/\/doi.org\/10.1038\/s41419-021-04378-0","journal-title":"Cell Death Dis"},{"issue":"1","key":"10146_CR85","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2020","unstructured":"Catalano M, O\u2019Driscoll L (2020) Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles 9(1):1703244. https:\/\/doi.org\/10.1080\/20013078.2019.1703244","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"10146_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12114","volume":"10","author":"G D'Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Gabrielli M, Scaroni F, Swuec P, Amin L, Pegoraro A et al (2021) Astrocytes-derived extracellular vesicles in motion at the neuron surface: involvement of the prion protein. J Extracell Vesicles 10(9):e12114. https:\/\/doi.org\/10.1002\/jev2.12114","journal-title":"J Extracell Vesicles"},{"key":"10146_CR87","doi-asserted-by":"publisher","unstructured":"Falzoni S, Vultaggio-Poma V, Chiozzi P, Tarantini M, Adinolfi E, Boldrini P et al (2024) The P2X7 receptor is a master regulator of microparticle and mitochondria exchange in mouse microglia. Function (Oxf) 5(4).\u00a0https:\/\/doi.org\/10.1093\/function\/zqae019","DOI":"10.1093\/function\/zqae019"},{"issue":"2","key":"10146_CR88","doi-asserted-by":"publisher","first-page":"859","DOI":"10.7150\/thno.66274","volume":"12","author":"V Vultaggio-Poma","year":"2022","unstructured":"Vultaggio-Poma V, Falzoni S, Chiozzi P, Sarti AC, Adinolfi E, Giuliani AL et al (2022) Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation. Theranostics 12(2):859\u2013874. https:\/\/doi.org\/10.7150\/thno.66274","journal-title":"Theranostics"},{"issue":"9","key":"10146_CR89","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-021-04069-w","volume":"12","author":"W Palinski","year":"2021","unstructured":"Palinski W, Monti M, Camerlingo R, Iacobucci I, Bocella S, Pinto F et al (2021) Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients. Cell Death Dis 12(9):797. https:\/\/doi.org\/10.1038\/s41419-021-04069-w","journal-title":"Cell Death Dis"},{"issue":"21","key":"10146_CR90","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1038\/s41388-022-02297-8","volume":"41","author":"S Chadet","year":"2022","unstructured":"Chadet S, Allard J, Brisson L, Lopez-Charcas O, Lemoine R, Heraud A et al (2022) P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition. Oncogene 41(21):2920\u20132931. https:\/\/doi.org\/10.1038\/s41388-022-02297-8","journal-title":"Oncogene"},{"issue":"1","key":"10146_CR91","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11302-022-09874-2","volume":"19","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhu S, Tan S, Zeng Y, Zeng H (2023) The P2 purinoceptors in prostate cancer. Purinergic Signal 19(1):255\u2013263. https:\/\/doi.org\/10.1007\/s11302-022-09874-2","journal-title":"Purinergic Signal"},{"key":"10146_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189043","author":"WHJ Ho","year":"2025","unstructured":"Ho WHJ, Lam KP (2025) Possible roles for purinergic receptor P2RX4 in breast and prostate cancers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26189043","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10146_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-025-04023-6","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Gu Y, Niu Z, Tang F, Li Y (2025) P2RX4 promotes hepatocellular carcinoma progression via calcium-mediated PI3K\/AKT activation and immune remodeling. World J Surg Oncol 23(1):363. https:\/\/doi.org\/10.1186\/s12957-025-04023-6","journal-title":"World J Surg Oncol"},{"key":"10146_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111472","author":"C Dillard","year":"2021","unstructured":"Dillard C, Borde C, Mohammad A, Puchois V, Jourdren L, Larsen AK et al (2021) Expression pattern of purinergic signaling components in colorectal cancer cells and differential cellular outcomes induced by extracellular ATP and adenosine. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111472","journal-title":"Int J Mol Sci"},{"issue":"7939","key":"10146_CR95","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-022-05426-1","volume":"612","author":"M Schmitt","year":"2022","unstructured":"Schmitt M, Ceteci F, Gupta J, Pesic M, Bottger TW, Nicolas AM et al (2022) Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation. Nature 612(7939):347\u2013353. https:\/\/doi.org\/10.1038\/s41586-022-05426-1","journal-title":"Nature"},{"issue":"10","key":"10146_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113517","volume":"28","author":"K Zhou","year":"2025","unstructured":"Zhou K, Zhang X, Liang Y, Yao H, Hou Y, Zhang X et al (2025) M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor. iScience 28(10):113517. https:\/\/doi.org\/10.1016\/j.isci.2025.113517","journal-title":"iScience"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10146-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10146-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10146-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:01:25Z","timestamp":1777611685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10146-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10146"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10146-6","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval is not applicable as this is a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29"}}